| Literature DB >> 26341705 |
Monika Pobiega1, Joanna Maciąg2, Agnieszka Chmielarczyk3, Dorota Romaniszyn3, Monika Pomorska-Wesolowska4, Grzegorz Ziolkowski5, Piotr B Heczko3, Malgorzata Bulanda3, Jadwiga Wojkowska-Mach3.
Abstract
Due to the clinical threat posed by multidrug-resistant (MDR) Pseudomonas aeruginosa and importance of virulence factors produced in infection, 21 carbapenem-resistant P. aeruginosa were analyzed. 42.8% metallo-beta-lactamases-positive strains were identified. 85.7% of strains were meropenem resistant. 14.2% of strains were MDR; 38%, extensively drug-resistant (XDR). ExoY was present in all strains; exoT, in 95.2%; exoS, in 90.5%; exoU, in 47.6%. Eight XDR strains were typed using multilocus sequence typing: 4 as ST235, 2 as ST260, 2 as ST654 and ST234. MDR P. aeruginosa were isolated from hospitalized patients and among those from the community. Our study demonstrates the serious clinical issues posed by MDR P. aeruginosa and underscores the need for new treatment.Entities:
Keywords: Carbapenem-resistance; MLST; Pseudomonas aeruginosa; exo
Mesh:
Substances:
Year: 2015 PMID: 26341705 DOI: 10.1016/j.diagmicrobio.2015.07.022
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803